A proof-of-concept trial has shown that zoledronic acid is effective in preventing bone erosions in patients with early rheumatoid arthritis (RA). Zoledronic acid is a third-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback